Skip to main contentSkip to navigation
Sirius Investors
Hofseth BioCare ASA

Hofseth BioCare ASA

HOFBF
OTCConsumer Defensive

Hofseth BioCare ASA (HOFBF) Investment Research Dashboard

About Hofseth BioCare ASA (HOFBF) stock analysis

Get live HOFBF stock price $0.17, comprehensive Hofseth BioCare ASA stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time HOFBF stock data and investment insights.

0.17
0.00%Today
Market Cap
68.47M
Volume
67.50K
52W High
0.18
52W Low
0.17

Loading chart data...

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Hofseth BioCare ASA is a company specializing in the development and supply of premium, marine-derived ingredients for various applications in both human and animal health. Its market presence extends from Norway to an international scale. The compan...

Company Information

CEO
Jon Olav Odegard
Sector
Consumer Defensive
Industry
Biotechnology
Employees
84

Contact Information

Address
Keiser Wilhelmsgate 24
Country
NO

Investment Analysis & Business Insights

Consumer Defensive
Biotechnology

Investment Highlights

Strong presence in the Consumer Defensive sector with established market position

Lower volatility stock (Beta: 0.26) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Hofseth BioCare ASA shareholders
  • Market volatility can significantly impact stock price, especially for smaller companies
  • Sector-specific risks in Consumer Defensive may affect company performance
  • Past performance does not guarantee future results for Hofseth BioCare ASA
  • Investors should consider how Hofseth BioCare ASA fits within their overall portfolio allocation
  • Valuation metrics suggest potential, but require fundamental analysis

Market Cap

68.47M

P/E Ratio (TTM)

-5.87

Beta

0.26

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Consumer Defensive Sector

The Consumer Defensive sector includes companies that provide essential products and services that consumers need regardless of economic conditions.

Consumer Defensive (1D)

56/100 ⭐⭐⭐⭐

Overall
-0.2%
NYSE
-0.1%
NASDAQ
-0.4%
Sector1D1W1MP/EScore
Financial Services+2.2%+5.7%+6.1%19.3
98/100⭐⭐⭐⭐⭐
Communication Services+1.4%+2.9%+4.3%22.2
86/100⭐⭐⭐⭐⭐
Healthcare+0.7%+3.3%+3.5%24.1
80/100⭐⭐⭐⭐⭐
Basic Materials+0.4%+1.1%-0.2%25.2
56/100⭐⭐⭐⭐
Consumer Defensive-0.2%+1.7%+1.2%29.7
56/100⭐⭐⭐⭐
Real Estate-0.5%-0.1%-1.6%29.2
43/100⭐⭐⭐
Energy-2.1%-5.8%-5.1%19.1
39/100⭐⭐
Utilities-1.0%-3.0%-5.9%26.8
28/100⭐⭐
Industrials+0.6%+1.7%-11.2%30.1
26/100⭐⭐
Consumer Cyclical+0.5%-0.4%-6.3%43.0
21/100
Technology+0.6%-2.3%-9.6%40.7
17/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-29.